Norway· NO-ID_BA5CE327-5DD2-4EBA-B327-42C6FDE4B38E
Farydak
A panobinostat product containing panobinostat, registered in Norway by pharmaand GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Panobinostat is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XH03 (panobinostat), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Panobinostat · ATC L01XH03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Panobinostat
- Manufacturer
- pharmaand GmbH
- Country
- Norway (NO)
- ATC code
- L01XH03
- ATC class
- Panobinostat
- Defined daily dose
- 5.7 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_BA5CE327-5DD2-4EBA-B327-42C6FDE4B38E
- no_varenummer1715926NOK 47898.5
- gtin373116325153
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
586 interactions on record for panobinostat.
Graded by severity as the source publishes them — 388 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Panobinostat · interactions on record
586 records
- 388 severe
- 193 moderate
- 5 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Panobinostat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFARYDAKpharmaand GmbH, Vienna
- SwitzerlandFarydak 10 mg, Hartkapselnmmpharm GmbH
- FinlandFarydakpharmaand GmbH
- FranceFARYDAK 10 mg, gélulePHARMAAND (AUTRICHE)
- United KingdomFarydak 10mg capsulespharmaand GmbH
- IrelandFarydak 10 mg hard capsulespharmaand GmbH
- IcelandFarydakPharmaand GmbH
- NetherlandsFarydak 10 mg harde capsuleszr pharma& GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Farydak
- Liechtenstein · Farydak
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15393c6a-545c-4d6a-90b4-f206a02f0a35 GET /v1/drugs/15393c6a-545c-4d6a-90b4-f206a02f0a35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Panobinostat",
"merkevare_id": "ID_BA5CE327-5DD2-4EBA-B327-42C6FDE4B38E",
"name_form_strength": "Farydak kaps 10 mg",
"prescription_group": "C"
}See everything about panobinostat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.